[1]
D. Abinaya, A. Rajendran, D. Manoharan, V. G. Hari, and V. Yelugoti, “Study of mutation profile in myelofibrosis and response to low dose ruxolitinib: a tertiary care experience”, Int J Adv Med, vol. 12, no. 2, pp. 175–179, Jan. 2025.